Haddadin Yezan Munther - Insider Non-Derivative Transactions at Outlook Therapeutics, Inc. (OTLK) - (SEC)
Updated on December 12, 2024.
According to recent SEC insider information filed on Mar 28, 2024, Haddadin Yezan Munther's relationship to Outlook Therapeutics, Inc. (OTLK) is Director, and currently has 5,048.71 shares of Common Stock.
The chart below shows the number of shares owned, and the table shows the recent insider transactions.
You can see similar information for other OTLK insiders.
Data Source: SEC.
Haddadin Yezan Munther - Insider Non-Derivative Transactions at OTLK
Items per page:
0 of 0
| Date | Transaction | No. of Shares | Price Per Share | Shares Owned After Transactions |
|---|---|---|---|---|
| Mar 29, 2024 | P -- (Common Stock) | 1881.71 | 11.82 | 5048.71 |